Used as a migraine treatment and administered rectally. For the preparation of suppositories, a hard fat with a low peroxide value (= 0.5) should be used and 2 mg of tartaric acid per suppository should be added for stabilisation (prevents the isomerisation of ergotamine tartrate). This item is subject to the German Precursor Control Act for drug precursors. An end-use declaration must therefore also be sent with your order.
You can find the end-use declaration here.
Click here for MSDS